| Literature DB >> 27437438 |
Kaiwei Si1, Linlin Wei2, Xiaozhuo Yu1, Feng Wu3, Xiaoqi Li1, Chen Li1, Yanbin Cheng1.
Abstract
Toxoplasma gondii pathogen is a threat to human health that results in economic burden. Unfortunately, there are very few high-efficiency and low-toxicity drugs for toxoplasmosis in the clinic. (+)-Usnic acid derived from lichen species has been reported to have anti-inflammatory, antibacterial, anti-parasitology, and even anti-cancer activities. In associated with the published article "Effects of (+)-Usnic Acid and (+)-Usnic Acid-Liposome on Toxoplasma gondii" [1], this dataset article provided the detailed information of experimental designing, methods, features as well as the raw data of (+)-usnic acid and (+)-usnic acid-liposome on toxoplasma in vivo and vitro. (+)-Usnic acid may be a potential agent for treating toxoplasmosis.Entities:
Keywords: (+)-Usnic acid; (+)-Usnic acidliposome; Liposome; Tachyzoite; Toxoplasma gondii
Year: 2016 PMID: 27437438 PMCID: PMC4939410 DOI: 10.1016/j.dib.2016.06.011
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Time- and concentration-dependent relationship of (+)-usnic acid on Toxoplasma gondii.
Fig. 2Effects of (+)-usnic acid on Toxoplasma gondii tachyzoites with Giemsa staining.
Fig. 3Effect of (+)-usnic acid on the invasion of toxoplasma to cardiofibroblast cells.
Fig. 4Effect of (+)-usnic acid and (+)-usnic acid–liposome on the acute toxoplasmosis in mice.
Fig. 5Observation of ultrastructural changes of tachyzoite in mice.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |